AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023 Read more
First-in-class DLL3-targeting BiTE could be the next big player in SCLC treatment: GlobalData Read more
AstraZeneca’s Durvalumab gets CDSCO nod to treat locally advanced or metastatic biliary tract cancer Read more
Sanofi and IGM Biosciences announce collaboration agreement for oncology, immunology and inflammation targets Read more